cabozantinib,nivolumab
exelixis,bms
['9er', 'kcsm,(-skcsm)', 'rcc,(-irccs),(-srcc),(-urcc)']
association between depth of response and clinical outcomes: exploratory analysis in patients with rcc in checkmate 9er #asco22 #kcsm 
Medical Oncologist MD, PhD, BSc (Biol), GU & GYN cancers, Visiting Scholar UPenn, Athens Medical Center